Methotrexate for rheumatoid arthritis
55 results
1 - 55
Methotrexate for treating rheumatoid arthritis- Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
- Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis
- Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis
- Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
- Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis
- Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
- Rituximab for rheumatoid arthritis
- Adalimumab for treating rheumatoid arthritis
- Infliximab for the treatment of rheumatoid arthritis
- Penicillamine for treating rheumatoid arthritis
- Golimumab for rheumatoid arthritis
- Tocilizumab for rheumatoid arthritis
- Etanercept for the treatment of rheumatoid arthritis
- Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
- Auranofin versus placebo in rheumatoid arthritis
- Methotrexate for psoriatic arthritis
- Cyclophosphamide for treating rheumatoid arthritis
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta‐analysis
- Leflunomide for the treatment of rheumatoid arthritis
- Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
- Perioperative use of disease‐modifying anti‐rheumatic drugs (DMARDs) in people with inflammatory arthritis
- Disease‐modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta‐analysis
- Methotrexate for ankylosing spondylitis
- Antidepressants for pain management in rheumatoid arthritis
- Methotrexate for induction of remission in refractory Crohn's disease
- Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)